Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

NCT02098278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipoprotein Lipase Deficiency, Familial
Hyperlipoproteinemia Type I
Chylomicronemia, Familial
Hypertriglyceridemia

Interventions

DRUG: CAT-2003
DRUG: Placebo

Sponsor

Catabasis Pharmaceuticals